Corcept Therapeutics (CORT) Competitor Comparison
We are evaluating the key criteria listed to compare Corcept Therapeutics (CORT) against its competitors in the Biotechnology industry.
Market Capitalization
69 / 368Gross Profits
19 / 278Total Revenue
25 / 300EBITDA
17 / 337Free Cashflow
11 / 352Quick Ratio
249 / 357Earnings per Share
18 / 359Dividend yield
0 / 6Total Cash
87 / 358Performance 3 years
35 / 368Performance 5 years
29 / 368Performance 10 years
5 / 368Linearity 3 years
351 / 368Linearity 5 years
364 / 368Linearity 10 years
359 / 368Total Rank
92 / 368Dividend Rank
46 / 368Valuation Rank
163 / 368Piotroski Rank
21 / 368Muliplier Rank
316 / 368Linearity 10 years - CORT ranking 359 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.